[CRVS] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
03-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -19.11%
YoY- -226.79%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -14,981 -16,036 -11,086 -10,297 -8,645 -6,347 -6,039 83.35%
Tax 0 0 -184 0 0 0 17,600 -
NP -14,981 -16,036 -11,086 -10,297 -8,645 -6,347 -6,039 83.35%
Tax Rate - - - - - - - -
Total Cost 14,981 16,036 11,086 10,297 8,645 6,347 6,039 83.35%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.73 -0.79 -0.55 -0.51 -0.43 -5.39 -0.68 4.84%
EPS Diluted -0.73 -0.79 -0.55 -0.51 -0.43 -5.39 -0.68 4.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.